vs
ICON PLC（ICLR）与OmniAb, Inc.（OABI）财务数据对比。点击上方公司名可切换其他公司
ICON PLC的季度营收约是OmniAb, Inc.的243.9倍（$2.0B vs $8.4M）。ICON PLC净利率更高（0.1% vs -169.3%，领先169.4%）。ICON PLC同比增速更快（0.6% vs -22.5%）。ICON PLC自由现金流更多（$333.9M vs $-5.7M）。过去两年OmniAb, Inc.的营收复合增速更高（48.4% vs 0.6%）
ICON plc是总部位于爱尔兰的跨国医疗智能与临床研究服务机构，专注为全球医药健康领域客户提供专业研究及情报支持，截至2025年2月，已在全球55个国家布局业务，员工规模约4.19万人。
OmniAb, Inc.是一家跨国生物技术企业，拥有专利转基因动物平台及全流程抗体发现解决方案，与全球制药和生物科技公司合作，加速肿瘤、自身免疫病等刚需医疗领域的全人源治疗抗体开发。
ICLR vs OABI — 直观对比
营收规模更大
ICLR
是对方的243.9倍
$8.4M
营收增速更快
ICLR
高出23.1%
-22.5%
净利率更高
ICLR
高出169.4%
-169.3%
自由现金流更多
ICLR
多$339.6M
$-5.7M
两年增速更快
OABI
近两年复合增速
0.6%
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $8.4M |
| 净利润 | $2.4M | $-14.2M |
| 毛利率 | — | — |
| 营业利润率 | 4.2% | -188.2% |
| 净利率 | 0.1% | -169.3% |
| 营收同比 | 0.6% | -22.5% |
| 净利润同比 | -98.8% | -8.5% |
| 每股收益（稀释后） | $0.03 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICLROABI
| Q4 25 | — | $8.4M | ||
| Q3 25 | $2.0B | $2.2M | ||
| Q2 25 | $2.0B | $3.9M | ||
| Q1 25 | $2.0B | $4.2M | ||
| Q4 24 | — | $10.8M | ||
| Q3 24 | $2.0B | $4.2M | ||
| Q2 24 | $2.1B | $7.6M | ||
| Q1 24 | $2.1B | $3.8M |
净利润ICLROABI
| Q4 25 | — | $-14.2M | ||
| Q3 25 | $2.4M | $-16.5M | ||
| Q2 25 | $183.0M | $-15.9M | ||
| Q1 25 | $154.2M | $-18.2M | ||
| Q4 24 | — | $-13.1M | ||
| Q3 24 | $197.1M | $-16.4M | ||
| Q2 24 | $146.9M | $-13.6M | ||
| Q1 24 | $187.4M | $-19.0M |
营业利润率ICLROABI
| Q4 25 | — | -188.2% | ||
| Q3 25 | 4.2% | -810.2% | ||
| Q2 25 | 10.4% | -416.2% | ||
| Q1 25 | 11.0% | -453.6% | ||
| Q4 24 | — | -147.0% | ||
| Q3 24 | 14.1% | -473.7% | ||
| Q2 24 | 10.8% | -214.1% | ||
| Q1 24 | 13.7% | -593.3% |
净利率ICLROABI
| Q4 25 | — | -169.3% | ||
| Q3 25 | 0.1% | -738.1% | ||
| Q2 25 | 9.1% | -407.4% | ||
| Q1 25 | 7.7% | -438.1% | ||
| Q4 24 | — | -121.0% | ||
| Q3 24 | 9.7% | -392.4% | ||
| Q2 24 | 6.9% | -179.0% | ||
| Q1 24 | 9.0% | -498.8% |
每股收益（稀释后）ICLROABI
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $0.03 | $-0.14 | ||
| Q2 25 | $2.30 | $-0.15 | ||
| Q1 25 | $1.90 | $-0.17 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $2.36 | $-0.16 | ||
| Q2 24 | $1.76 | $-0.13 | ||
| Q1 24 | $2.25 | $-0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $468.9M | $25.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $9.3B | $267.0M |
| 总资产 | $16.5B | $300.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ICLROABI
| Q4 25 | — | $25.5M | ||
| Q3 25 | $468.9M | $28.5M | ||
| Q2 25 | $390.4M | $18.3M | ||
| Q1 25 | $526.7M | $10.9M | ||
| Q4 24 | — | $27.6M | ||
| Q3 24 | $695.5M | $27.2M | ||
| Q2 24 | $506.6M | $20.8M | ||
| Q1 24 | $396.1M | $19.1M |
股东权益ICLROABI
| Q4 25 | — | $267.0M | ||
| Q3 25 | $9.3B | $277.4M | ||
| Q2 25 | $9.6B | $262.1M | ||
| Q1 25 | $9.5B | $273.5M | ||
| Q4 24 | — | $287.6M | ||
| Q3 24 | $9.8B | $291.7M | ||
| Q2 24 | $9.6B | $294.2M | ||
| Q1 24 | $9.4B | $301.4M |
总资产ICLROABI
| Q4 25 | — | $300.9M | ||
| Q3 25 | $16.5B | $309.7M | ||
| Q2 25 | $16.6B | $295.7M | ||
| Q1 25 | $16.7B | $306.2M | ||
| Q4 24 | — | $325.6M | ||
| Q3 24 | $17.2B | $331.6M | ||
| Q2 24 | $17.0B | $337.3M | ||
| Q1 24 | $17.0B | $352.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $387.6M | $-5.7M |
| 自由现金流经营现金流 - 资本支出 | $333.9M | $-5.7M |
| 自由现金流率自由现金流/营收 | 16.3% | -67.8% |
| 资本支出强度资本支出/营收 | 2.6% | 0.1% |
| 现金转化率经营现金流/净利润 | 164.59× | — |
| 过去12个月自由现金流最近4个季度 | $1.0B | $-37.0M |
8季度趋势，按日历期对齐
经营现金流ICLROABI
| Q4 25 | — | $-5.7M | ||
| Q3 25 | $387.6M | $-9.8M | ||
| Q2 25 | $146.2M | $-5.1M | ||
| Q1 25 | $268.2M | $-15.9M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | $402.7M | $-6.6M | ||
| Q2 24 | $218.6M | $-12.2M | ||
| Q1 24 | $327.1M | $-17.0M |
自由现金流ICLROABI
| Q4 25 | — | $-5.7M | ||
| Q3 25 | $333.9M | $-9.9M | ||
| Q2 25 | $113.9M | $-5.3M | ||
| Q1 25 | $239.3M | $-16.1M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | $359.3M | $-6.7M | ||
| Q2 24 | $182.3M | $-12.9M | ||
| Q1 24 | $299.9M | $-18.0M |
自由现金流率ICLROABI
| Q4 25 | — | -67.8% | ||
| Q3 25 | 16.3% | -444.2% | ||
| Q2 25 | 5.6% | -136.3% | ||
| Q1 25 | 12.0% | -387.1% | ||
| Q4 24 | — | -36.3% | ||
| Q3 24 | 17.7% | -161.3% | ||
| Q2 24 | 8.6% | -169.9% | ||
| Q1 24 | 14.3% | -472.5% |
资本支出强度ICLROABI
| Q4 25 | — | 0.1% | ||
| Q3 25 | 2.6% | 8.1% | ||
| Q2 25 | 1.6% | 4.2% | ||
| Q1 25 | 1.4% | 5.0% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | 2.1% | 3.6% | ||
| Q2 24 | 1.7% | 9.9% | ||
| Q1 24 | 1.3% | 24.4% |
现金转化率ICLROABI
| Q4 25 | — | — | ||
| Q3 25 | 164.59× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.04× | — | ||
| Q2 24 | 1.49× | — | ||
| Q1 24 | 1.74× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICLR
| Other Customers | $681.3M | 33% |
| Clients1125 | $549.4M | 27% |
| Clients15 | $503.3M | 25% |
| Clients610 | $308.8M | 15% |
OABI
暂无分部数据
